Login

Dr. Dawn Jaroszewski, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Jaroszewski shares why she chose to build her career at an iconic institution like Mayo Clinic.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
GHL Systems Berhad: CEO and IR Director Briefing | SEAN S. HESH - Group Chief Executive Officer of GHL Systems Berhad
00:10:00
Michael Watson: Reflections on Politics and Activism|Michael Walzer,Professor,Institute for Advanced Studies
00:00:00
Tom Ulich, CSO, InVivo Therapeutics Holdings Corp
00:10:00
Cutting-Edge Cancer Therapies and Financial Strategies at the Biotech Showcase in San Francisco| Sadesh Seth , CEO, Actinium Pharmaceuticals Inc.
00:10:00
Locaweb’s Fernando Cirne Attributes Success to Pre-Crisis Growth Strategies | Fernando Cirne, CEO , Locaweb Serviços De Internet SA.
00:10:00
Exclusive Tour: Inside Blue Bird's Facility with CEO Phil Horlock | Phil Horlock - CEO of Blue Bird Corporation
00:10:00
Prolific investors and inspiring entrepreneurs talk candidly about the complex venture landscape|Armaan Ali,Co-Founder, CEO, and Managing Partner,Human Capital
00:10:00
U.S. Leadership in Emerging Technologies: Insights from Lux Capital's Josh Wolff | Josh Wolfe, Co-Founder, Lux Capital .
00:10:00
In a discussion with Nick Bolton, CEO of Oxford Metrics Plc, hosted by Oli Barrett MBE, marking the third consecutive year of the event.
00:10:00
Howard Marks on Debt Investing and the End of Low-Interest Regimes: Insights from Oaktree Capital's Co-Founder and Co-Chairman
00:10:00
Revolutionizing School Finance: A Transparent, Portable, and Equitable System by 2030
00:10:00
Unleash the power of Startups in Turkey|Dilek Dayinlarli,General Partner, ScaleX Ventures

© 2026 Nehu